Insider trades › MetLife › Marlene Debel
Marlene Debel: MetLife stock transactions
Marlene Debel (EVP & Chief Risk Officer at MetLife) reported 1 transaction in MET stock on SEC Form 4 over the last 120 days. Name as filed with the SEC: DEBEL MARLENE.
$0open-market sales (0 shares)
$0open-market purchases (0 shares)
2026-08-31most recent transaction
Transactions
| Date | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|
| Aug 31, 2026 | Shares withheld for tax | 4,030 | $95.17 | — | Form 4 ↗ |
Source: SEC EDGAR Form 4 filings; each row links to the filing. Sales marked "10b5-1 plan" were reported as made under a pre-arranged trading plan. Insider trades are reported facts, not recommendations. Not investment advice.